MedPath

Questionnaires to Identify Chinese Patients at Risk for Obstructive Sleep Apnea

Completed
Conditions
Obstructive Sleep Apnea
Registration Number
NCT01171196
Lead Sponsor
The University of Hong Kong
Brief Summary

The purpose of this study is to validate the Berlin questionnaire and STOP-BANG (snore, tired, obstruction, pressure, body mass index (BMI), age, neck, gender) as effective screening tools for Chinese subjects who are suspected to have obstructive sleep apnea (OSA).

Detailed Description

Obstructive sleep apnea (OSA) is a common sleep related breathing disorder associated with excessive daytime sleepiness and cardiovascular disease. It is prevalent in both western (4-26%) and eastern countries (4-19%). In recent studies, it has been estimated that at least 70-80% of middle aged individuals with sleep apnea are undiagnosed and untreated. The prevalence of undiagnosed OSA subjects within the community suggests the need for a greater awareness and a high index of suspicion of this disease entity as well as its associated short- and long-term comorbidities.

A reliable and easy-to-use screening questionnaire is required for efficient prediction of OSA and treatment arrangement. It would be helpful to prioritize patients who require sleep study according to the probability of suffering from sleep apnea. It reduces the use of sleep study for those with low probability of having OSA, but giving treatment to those who are with more severe OSA first. Meanwhile, it enhances the cost effective management of disease especially with limited resources in our society.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
378
Inclusion Criteria

a. No known history of any sleep disorder

Exclusion Criteria
  1. History of heavy alcoholism ( ≥ 3 times / week)
  2. Underlying pulmonary diseases
  3. Recent upper respiratory tract infection in the past one week
  4. Unstable medical conditions
  5. Pregnancy
  6. History of psychiatric illness

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To validate the Berlin questionnaire and STOP-BANG as effective screening toolsat the time of completing the questionnaire

To validate the Berlin questionnaire and STOP-BANG as effective screening tools for Chinese subjects who are suspected to have OSA

Secondary Outcome Measures
NameTimeMethod
the predictive performance on OSA of Berlin questionnaire and STOP-BANGat the time of completing questionnaire

To compare the predictive performance on OSA of Berlin questionnaire and STOP-BANG in our Chinese population

Trial Locations

Locations (1)

Queen Mary Hospital

🇭🇰

Hong Kong Island, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath